Dr. Leapman has been recognized for his research in urologic oncology, with an emphasis in prostate cancer, particularly in the area of risk stratification and clinical outcomes research. His work has been published widely including the Journal of Clinical Oncology, JAMA Oncology, European Urology, and the Journal of Urology. He has written numerous review articles and book chapters, and has delivered research presentations and invited lectures at regional and national meetings.
Urinary Bladder Diseases; Delivery of Health Care; Health Services Research; Kidney Diseases; Prostatic Neoplasms; Ureteral Diseases; Urologic Neoplasms